Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein

被引:16
作者
Zhang, Jing [1 ]
Yamada, Osamu [1 ]
Matsushita, Yoshihisa [1 ]
Chagan-Yasutan, Haorile [2 ]
Hattori, Toshio [2 ]
机构
[1] FUSO Pharmaceut Ind Ltd, Ctr Res & Dev, Joto Ku, Osaka 5368523, Japan
[2] Tohoku Univ, Sch Med, Dept Infect & Resp Dis, Sendai, Miyagi 980, Japan
关键词
HTLV-1; Tax; Transactivation; Osteopontin; PI3K/AKT; AP-1; NF-KAPPA-B; MAMMARY EPITHELIAL-CELLS; HEPATITIS-C VIRUS; HTLV-1; TAX; BREAST-CANCER; TRANSCRIPTIONAL REGULATION; HTLV-1-TRANSFORMED CELLS; TRANSFORMED-CELLS; SIGNALING PATHWAY; TRANSGENIC MICE;
D O I
10.1016/j.leukres.2009.08.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteopontin (OPN) is a cytokine that contributes substantially to the growth and metastasis in a wide spectrum of malignancies. We report here that OPN gene is transactivated by Tax protein of human T-cell leukemia virus type 1 (HTLV-1). Northern blot showed enhanced OPN gene expression in cells stably expressing Tax. Co-expression of Tax increased the reporter gene expression directed by OPN promoter. Tax-induced OPN activation was abrogated by treatment with LY294002 (PI3K inhibitor) or co-transfection with AKT siRNA, suggesting PI3K/AKT pathway is involved in Tax-mediated transactivation. Reporter assay with deletion mutants showed that the 5'-partial sequence between -765 and -660 of the OPN promoter is the region responsive to Tax, and further, disrupting the AP-1 site within this region abolished the OPN induction by Tax, indicating that Tax activation of OPN promoter is likely mediated by AP-1 site. This study suggests that OPN is one of the downstream mediators of aberrantly activated PI3K/AKT signaling by Tax, which may partially contribute to HTLV-1-associated leukemogenesis. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:763 / 768
页数:6
相关论文
共 50 条
[41]   The Cellular Autophagy Pathway Modulates Human T-Cell Leukemia Virus Type 1 Replication [J].
Tang, Sai-Wen ;
Chen, Chia-Yen ;
Klase, Zachary ;
Zane, Linda ;
Jeang, Kuan-Teh .
JOURNAL OF VIROLOGY, 2013, 87 (03) :1699-1707
[42]   Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression [J].
Lin, HC ;
Hickey, M ;
Hsu, L ;
Medina, D ;
Rabson, AB .
VIROLOGY, 2005, 339 (01) :1-11
[43]   Is there a role for ubiquitin or SUMO in human T-cell leukemia virus type 2 Tax-induced NE-κB activation? [J].
Lavorgna, Alfonso ;
Harhaj, Edward W. .
FUTURE VIROLOGY, 2013, 8 (03) :223-227
[44]   Functional activities of the human T-cell leukemia virus type I Tax oncoprotein:: cellular signaling through NF-κB [J].
Jeang, KT .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (2-3) :207-217
[45]   Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I [J].
Iwanaga, R ;
Ohtani, K ;
Hayashi, T ;
Nakamura, M .
ONCOGENE, 2001, 20 (17) :2055-2067
[46]   Lack of Recall Response to Tax in ATL and HAM/TSP Patients But Not in Asymptomatic Carriers of Human T-cell Leukemia Virus Type 1 [J].
Manuel, Sharron L. ;
Sehgal, Mohit ;
Connolly, John ;
Makedonas, George ;
Khan, Zafar K. ;
Gardner, Jay ;
Betts, Michael R. ;
Jain, Pooja .
JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (07) :1223-1239
[47]   Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation [J].
Mostoller, K ;
Norbury, CC ;
Jain, P ;
Wigdahl, B .
JOURNAL OF NEUROVIROLOGY, 2004, 10 (06) :358-371
[48]   Roles of miRNAs in virus-mediated cellular transformation: lessons from human T-cell leukemia virus type 1 [J].
Yeung, Man Lung ;
Jeang, Kuan-Teh .
FUTURE VIROLOGY, 2011, 6 (11) :1351-1360
[49]   Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax [J].
M Sasaki ;
K Sugimoto ;
K Tamayose ;
M Ando ;
Y Tanaka ;
K Oshimi .
Oncogene, 2006, 25 :3621-3627
[50]   Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax [J].
Sasaki, M. ;
Sugimoto, K. ;
Tamayose, K. ;
Ando, M. ;
Tanaka, Y. ;
Oshimi, K. .
ONCOGENE, 2006, 25 (26) :3621-3627